We hope you enjoyed the July break. We're back with a look at a new measles record, and what BIO's saying about the One, Big, Beautiful Bill Act, drug patents, and more. (873 words, 4 minutes, 21 ...

Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named ...

We've come to the end of the 2025 BIO International Convention. On the final day, the theme is breakthroughs can't wait – celebrating the virtuous cycle of innovation.

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA): “The ...

That's a wrap. As we travel home from Boston, we take a look at why we do what we do – and hear from patient advocates who inspire us. Keep an eye on Bio.News for continued coverage all summer long, ...

Today we look at why the Pediatric Priority Review Voucher needs to be reauthorized, and how global collaboration can lead us to the "biological century." (640 words, 3 minutes, 12 seconds) BIO 2025: ...

BIO 2025 started with a multi-panel session featuring officials from the Administration for Strategic Preparedness and Response (ASPR) and the Department of Defense about how public-private ...

Day 2 brought current and former lawmakers at the federal and state levels to discuss how policy can advance progress. On Day 3, it's all about the patients. (804 words, 4 minutes, 1 seconds) Day 3: ...

A busy week on Capitol Hill brought BIO Board member testimony and developments on issues where BIO’s advocacy remains hyper-focused, including PPRV, ORPHAN Cures, and vaccination. Plus, ACIP stirs ...